Date	Period	Revenue/Estimate	Earnings Call
Oct 24, 2025	2025/Q3	-- / 320.425B	--
Jul 24, 2025	2025/Q2	-- / 323.135B	--
Apr 24, 2025	2025/Q1	288.500B / 261.540B	--
Jan 30, 2025	2024/Q4	302.111B / 290.332B	--
Oct 25, 2024	2024/Q3	315.700B / 280.871B	--

DatePeriodRevenue/EstimateEarnings Call

Oct 24, 20252025/Q3-- / 320.425B--

Jul 24, 20252025/Q2-- / 323.135B--

Apr 24, 20252025/Q1288.500B / 261.540B--

Jan 30, 20252024/Q4302.111B / 290.332B--

Oct 25, 20242024/Q3315.700B / 280.871B--

Unlock Free Earnings Estimates

Open Account

Chugai Pharmaceutical: Consolidated financial results for the 1st quarter of the fiscal year ending 2025/12 [IFRS] supplementary materials

Apr 24 04:00 ET

Chugai Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2025/12 [IFRS] (consolidated)

4519 Chugai Pharmaceutical

Chugai Pharmaceutical Key Stats